| Main Title |
Recombinant bovine growth hormone FDA approval should be withheld until the mastitis issue is resolved : report to Congressional requesters / |
| CORP Author |
United States. General Accounting Office. |
| Publisher |
The Office ; |
| Year Published |
1992 |
| Report Number |
GAO/PEMD-92-26;B-248450 |
| Stock Number |
147302 |
| OCLC Number |
26435332 |
| Subjects |
Bovine somatotropin--Research--United States--Evaluation ;
Mastitis--Chemotherapy--United States ;
Milk contamination--United States ;
Milk production--Technological innovations--United States--Evaluation
|
| Additional Subjects |
United States--Food and Drug Administration--Auditing
|
| Holdings |
| Library |
Call Number |
Additional Info |
Location |
Last
Modified |
Checkout
Status |
| EJEM |
SF768.2.C3 U55 1992 |
|
OCSPP Chemical Library/Washington,DC |
04/27/2015 |
|
| Collation |
64 p. ; 28 cm. |
| Notes |
Cover title. "August 1992." "GAO/PEMD-92-26." "B-248450"--P. 1. Includes bibliographical references. |
| Place Published |
Washington, D.C. : |
| PUB Date Free Form |
1992} |
| Ti Tra Differently |
FDA approval should be withheld until the mastitis issue is resolved. |
| BIB Level |
m |
| Cataloging Source |
OCLC/T |
| OCLC Time Stamp |
19920914151527 |
| Language |
ENG |
| SUDOCS Number |
GA 1.13:PEMD-92-26 |
| Origin |
OCLC |
| Type |
CAT |
| OCLC Rec Leader |
01459nam 2200349Ia 45010 |
